ANGICYTE
Live / Registered — Registered (as of 24 Jun 2025)
What this means for you
Registered since 24 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79399244
- Registration number
- 7838997
- Mark type
- Stylized text
- Filed
- 04 Mar 2024
- Published for opposition
- 06 May 2025
- Registered
- 24 Jun 2025
- Attorney of record
- Usha Menon
Goods and services
- Class 001 — Chemicals: Stem cells for research purposes; stem cells for scientific purposes; chemicals for use in manufacturing pharmaceuticals; reagents for research purposes; reagents for medical research; reagents for scientific purposes; diagnostic reagents for scientific or research use; cell culture reagents for scientific and research use; blood culture media for scientific use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of ischemic diseases; Drugs for medical purposes, namely, pharmaceutical preparations for the treatment of ischemic diseases; Pharmaceutical preparations containing stem cells for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Stem cells for medical purposes; cells for medical use; cell growth media for growing cells for medical use; living cells for medical use; cellular function activating agents for medical purposes; Vaccines; Reagents for medical use; medical diagnostic reagents
- Class 010 — Medical apparatus: Medical devices for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Medical apparatus and instruments for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Apparatus for the regeneration of stem cells for medical purposes; medical devices and apparatus for vascular regeneration and repair in the treatment of ischemic diseases; Medical devices and apparatus for cell therapy for the treatment of ischemic diseases and stimulation of vascular regeneration, blood vessel repair, and tissue revitalization; Blood testing apparatus
- Class 042 — Scientific and technological services: Medical and pharmacological research services; Stem cell research; Scientific research services for others relating to the isolation and cultivation of human tissues and cells; Research in the field of cell engineering technology; Scientific and medical research in the field of vascular regeneration and repair; Research and development of medicines; Pharmaceutical drug development services; Drug discovery services; Development of pharmaceutical preparations and medicines; Development of stem and progenitor cell therapies and other cell therapies; Research and development services in the medical field of cell therapy; research and development services in the medical field of vascular regeneration and repair; Scientific research in the nature of conducting clinical trials for others; Blood analysis services for scientific research purposes
- Class 044 — Medical, beauty and agricultural services: Regenerative medicine services; medical services; stem cell therapy services; cell therapy services; Stem cell therapy services for vascular regeneration and repair; cell therapy services relating to the generation of human vascular reparative cells; cell therapy services relating to the injecting, grafting or implanting of cells into patients; medical services relating to the removal, treatment and processing of cells; Medical services relating to the removal, treatment and processing of stem cells; Stem cell storage, namely, stem cell bank services; Cultured cell bank services for medical transplantation; medical laboratory services for the analysis of samples taken from patients; Medical analysis services for the diagnosis and treatment of persons; Services for the testing of blood, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical services relating to the removal, treatment and processing of human blood
Owner
- VASCVERSA LIMITED, GB
- VASCVERSA LIMITED, GB
- VASCVERSA LIMITED, GB
Prosecution history
- 12 Mar 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 19 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 05 Feb 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Jan 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Jan 2026 — FINAL DISPOSITION PROCESSED
- 18 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 03 Dec 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 24 Sept 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Jul 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED